PDCD1 and cancer: Across all cancers, MMR deficiency is correlated with TMB and TMB, predicted neoantigen load, TIL presence and MMR status all independently correlate positively with response rates to checkpoint blockade with a-PD1 and a-PD-L1 antibodies [30,51,64,66,67,68,69,70,71,72,73].